These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26612535)

  • 21. Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.
    Kang M; Jiang B; Xu B; Lu W; Guo Q; Xie Q; Zhang B; Dong X; Chen D; Wu Y
    Cancer Lett; 2013 Mar; 330(1):11-21. PubMed ID: 23200678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of mistaken identity? Nonductal origins of pancreatic "ductal" cancers.
    Murtaugh LC; Leach SD
    Cancer Cell; 2007 Mar; 11(3):211-3. PubMed ID: 17349578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When antimicrobial peptides hit the wrong target: a novel link between tumour macrophages and cancer stem cells.
    Diaferia GR; Natoli G
    Gut; 2015 Dec; 64(12):1841-2. PubMed ID: 25966994
    [No Abstract]   [Full Text] [Related]  

  • 26. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
    Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
    Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet cells contribute to pancreatic carcinogenesis in an animal model.
    El-Ghamari M; Bergmann F; Schmied BM; Weitz J; Ulrich A
    Pancreas; 2011 Mar; 40(2):242-6. PubMed ID: 21178650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Pancreas; 2015 May; 44(4):660-4. PubMed ID: 25760429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
    Gagliano N; Volpari T; Clerici M; Pettinari L; Barajon I; Portinaro N; Colombo G; Milzani A; Dalle-Donne I; Martinelli C
    Anticancer Drugs; 2012 Oct; 23(9):935-46. PubMed ID: 22700003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
    Bisht S; Brossart P; Maitra A; Feldmann G
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.
    Song X; Liu J; Lu Y; Jin H; Huang D
    Oncol Rep; 2014 Mar; 31(3):1191-8. PubMed ID: 24378899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
    Schäfer H; Geismann C; Heneweer C; Egberts JH; Korniienko O; Kiefel H; Moldenhauer G; Bachem MG; Kalthoff H; Altevogt P; Sebens S
    Carcinogenesis; 2012 Jan; 33(1):84-93. PubMed ID: 22095073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
    Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
    Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.
    Nielsen MF; Mortensen MB; Detlefsen S
    World J Gastroenterol; 2016 Mar; 22(9):2678-700. PubMed ID: 26973408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.
    Perera RM; Bardeesy N
    Cancer Discov; 2015 Dec; 5(12):1247-61. PubMed ID: 26534901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
    Mondo EL; Noel MS; Katz AW; Schoeniger LO; Hezel AF
    J Clin Oncol; 2013 Jan; 31(3):e37-9. PubMed ID: 23233707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.